Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients
Clinical trial NCT07290088 · RECRUITING
Trial details
- NCT number
- NCT07290088
- Sponsor
- Intra-IMMUSG Pte Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2026-12-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.